In-Vitro Diagnostics Instruments Global Market Report 2025

Description

In-vitro diagnostic instruments are medical devices used to analyze biological samples, such as blood, urine, or tissue, outside the human body. Their primary function is to detect, diagnose, monitor, and manage diseases or medical conditions by providing accurate and timely laboratory test results. These instruments aid clinical decision-making and support personalized patient care.

The primary product types of in-vitro diagnostic instruments include clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, coagulation, and others. Clinical chemistry instruments are digital tools, often leveraging AI, to analyze blood, urine, and other body fluids, helping identify biochemical abnormalities, improve diagnostic accuracy, and guide treatment planning. These instruments are applied across multiple areas, including infectious diseases, cancer, cardiology, nephrology, and autoimmune disorders. They serve a diverse range of end users, including hospitals, diagnostic laboratories, academic and research institutes, point-of-care facilities, blood banks, and pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The in-vitro diagnostics instruments market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics instruments market statistics, including in-vitro diagnostics instruments industry global market size, regional shares, competitors with a in-vitro diagnostics instruments market share, detailed in-vitro diagnostics instruments market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics instruments industry. This in-vitro diagnostics instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro diagnostics instruments market size has grown strongly in recent years. It will grow from $55.59 billion in 2024 to $61.09 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period is driven by increasing prevalence of chronic diseases, growing adoption of automated laboratory systems, rising awareness of preventive healthcare, increasing hospital and clinic infrastructure, and growing government funding for healthcare initiatives.

The in-vitro diagnostics instruments market size is expected to see rapid growth in the next few years. It will grow to $90.13 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period is driven by the increasing demand for personalized medicine, growing demand for rapid diagnostic tests, rising demand for home-based diagnostics, and increasing awareness of antimicrobial resistance. Primary trends in the forecast period include the development of miniaturized diagnostic devices, advancement in high-throughput platforms, integration with electronic health records, incorporation of robotics in laboratories, and innovation in biosensor technologies.

The rising prevalence of chronic and lifestyle related diseases is expected to enhance the growth of the in vitro diagnostics instruments market in the coming years. Chronic and lifestyle related diseases refer to long term health conditions primarily influenced by daily habits, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The incidence of these diseases is increasing due to sedentary lifestyles and unhealthy dietary habits. In vitro diagnostics instruments are experiencing higher demand as the growing burden of chronic and lifestyle related diseases encourages companies to adopt early detection and monitoring tools for improved disease management. For example, in 2024, according to the American Action Forum, a U.S. based non profit, center right think tank, chronic diseases remain a major public health concern in the United States, with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Furthermore, the chronic disease treatment market is projected to reach approximately 38.02 billion dollars by 2034, up from 9.74 billion dollars in 2025. Therefore, the rising prevalence of chronic and lifestyle related diseases is enhancing the growth of the in vitro diagnostics instruments market.

Prominent companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced technologies, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for next-generation diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic instruments that quantify DNA or RNA molecules by dividing samples into thousands of individual reactions, allowing for exceptional accuracy and sensitivity in detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its dPCR portfolio into clinical diagnostics with a primary focus on oncology testing. This fully integrated and automated system is specifically designed for clinical use, featuring a cartridge-based workflow that minimizes manual handling. Equipped with automated analysis and reporting software, the QIAcuityDx enables rapid and precise detection of genetic biomarkers for cancer diagnosis and therapy monitoring, reducing operator involvement while ensuring reliable and reproducible results.

In January 2025, Fremman Ltd., a UK-based investment company, acquired a majority stake in DIESSE Diagnostica Senese S.p.A. for an undisclosed amount. Through this acquisition, Fremman Ltd aims to expand DIESSE Diagnostica Senese's international presence, strengthen its leadership in specialty in vitro diagnostics, and support ongoing innovation to advance global diagnostic capabilities and improve patient outcomes. DIESSE Diagnostica Senese S.p.A. is an Italy-based medical equipment company that provides in vitro diagnostic instruments.

Major players operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, Laboratory Corporation of America Holdings (LabCorp), Guardant Health Inc., Quest Diagnostics Inc., Exact Sciences Corporation, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., NanoString Technologies Inc., Veracyte Inc., Invitae Corporation, Foundation Medicine Inc. (Roche), Caris Life Sciences, Personalis Inc., OncoCyte Corporation, Freenome Holdings Inc., Epic Sciences Inc.

North America was the largest region in the in-vitro diagnostics instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro diagnostics instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro diagnostics instruments market consists of sales of point-of-care testing devices, flow cytometry instruments, histopathology and cytology instruments, and molecular point-of-care systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Diagnostics Instruments Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro diagnostics instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro diagnostics instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro diagnostics instruments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Clinical Chemistry; Immunoassay; Molecular Diagnostics; Hematology; Microbiology; Coagulation; Other Product Types
2) By Application: Infectious Diseases; Cancer; Cardiology; Nephrology; Autoimmune Diseases; Other Applications
3) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Point-Of-Care Settings; Blood Banks; Pharmaceutical And Biotechnology Companies; Other Healthcare Facilities
Subsegments:
1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers; Semi-Automated Clinical Chemistry Analyzers; Point-Of-Care Clinical Chemistry Devices
2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems; Chemiluminescence Immunoassay (CLIA) Analyzers; Radioimmunoassay (RIA) Systems
3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Deoxyribonucleic Acid Microarrays; Isothermal Amplification Devices
4) By Hematology: Automated Hematology Analyzers; Manual Hematology Analyzers; Hemostasis Analyzers; Coagulation Analyzers
5) By Microbiology: Microbial Identification Systems; Antibiotic Susceptibility Testing (AST) Systems; Blood Culture Systems; Automated Microbial Analyzers.
6) By Coagulation: Coagulometers; Platelet Function Analyzers; Thromboelastography (TEG) Systems; Point-Of-Care Coagulation Devices
7) By Other Product Types: Point-Of-Care Diagnostic Devices; Clinical Chemistry Reagents; Diagnostic Imaging Instruments; Miscellaneous Laboratory Instruments
Companies Mentioned: F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, Laboratory Corporation of America Holdings (LabCorp), Guardant Health Inc., Quest Diagnostics Inc., Exact Sciences Corporation, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., NanoString Technologies Inc., Veracyte Inc., Invitae Corporation, Foundation Medicine Inc. (Roche), Caris Life Sciences, Personalis Inc., OncoCyte Corporation, Freenome Holdings Inc., Epic Sciences Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r39278

1. Executive Summary

2. In-Vitro Diagnostics Instruments Market Characteristics

3. In-Vitro Diagnostics Instruments Market Trends And Strategies

4. In-Vitro Diagnostics Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In-Vitro Diagnostics Instruments Growth Analysis And Strategic Analysis Framework

5.1. Global In-Vitro Diagnostics Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global In-Vitro Diagnostics Instruments Market Growth Rate Analysis
5.4. Global In-Vitro Diagnostics Instruments Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global In-Vitro Diagnostics Instruments Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global In-Vitro Diagnostics Instruments Total Addressable Market (TAM)

6. In-Vitro Diagnostics Instruments Market Segmentation

6.1. Global In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Chemistry
Immunoassay
Molecular Diagnostics
Hematology
Microbiology
Coagulation
Other Product Types
6.2. Global In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Cancer
Cardiology
Nephrology
Autoimmune Diseases
Other Applications
6.3. Global In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Laboratories
Academic And Research Institutes
Point-Of-Care Settings
Blood Banks
Pharmaceutical And Biotechnology Companies
Other Healthcare Facilities
6.4. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Clinical Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Clinical Chemistry Analyzers
Semi-Automated Clinical Chemistry Analyzers
Point-Of-Care Clinical Chemistry Devices
6.5. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA) Systems
Chemiluminescence Immunoassay (CLIA) Analyzers
Radioimmunoassay (RIA) Systems
6.6. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR) Systems
Next-Generation Sequencing (NGS) Platforms
Deoxyribonucleic Acid Microarrays
Isothermal Amplification Devices
6.7. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Hematology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Hematology Analyzers
Manual Hematology Analyzers
Hemostasis Analyzers
Coagulation Analyzers
6.8. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Microbiology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microbial Identification Systems
Antibiotic Susceptibility Testing (AST) Systems
Blood Culture Systems
Automated Microbial Analyzers.
6.9. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Coagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulometers
Platelet Function Analyzers
Thromboelastography (TEG) Systems
Point-Of-Care Coagulation Devices
6.10. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Point-Of-Care Diagnostic Devices
Clinical Chemistry Reagents
Diagnostic Imaging Instruments
Miscellaneous Laboratory Instruments

7. In-Vitro Diagnostics Instruments Market Regional And Country Analysis

7.1. Global In-Vitro Diagnostics Instruments Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global In-Vitro Diagnostics Instruments Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Diagnostics Instruments Market

8.1. Asia-Pacific In-Vitro Diagnostics Instruments Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Diagnostics Instruments Market

9.1. China In-Vitro Diagnostics Instruments Market Overview
9.2. China In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Diagnostics Instruments Market

10.1. India In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Diagnostics Instruments Market

11.1. Japan In-Vitro Diagnostics Instruments Market Overview
11.2. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Diagnostics Instruments Market

12.1. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Diagnostics Instruments Market

13.1. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Diagnostics Instruments Market

14.1. South Korea In-Vitro Diagnostics Instruments Market Overview
14.2. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Diagnostics Instruments Market

15.1. Western Europe In-Vitro Diagnostics Instruments Market Overview
15.2. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Diagnostics Instruments Market

16.1. UK In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Diagnostics Instruments Market

17.1. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Diagnostics Instruments Market

18.1. France In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Diagnostics Instruments Market

19.1. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Diagnostics Instruments Market

20.1. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Diagnostics Instruments Market

21.1. Eastern Europe In-Vitro Diagnostics Instruments Market Overview
21.2. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Diagnostics Instruments Market

22.1. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Diagnostics Instruments Market

23.1. North America In-Vitro Diagnostics Instruments Market Overview
23.2. North America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Diagnostics Instruments Market

24.1. USA In-Vitro Diagnostics Instruments Market Overview
24.2. USA In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Diagnostics Instruments Market

25.1. Canada In-Vitro Diagnostics Instruments Market Overview
25.2. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Diagnostics Instruments Market

26.1. South America In-Vitro Diagnostics Instruments Market Overview
26.2. South America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Diagnostics Instruments Market

27.1. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Diagnostics Instruments Market

28.1. Middle East In-Vitro Diagnostics Instruments Market Overview
28.2. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Diagnostics Instruments Market

29.1. Africa In-Vitro Diagnostics Instruments Market Overview
29.2. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Diagnostics Instruments Market Competitive Landscape And Company Profiles

30.1. In-Vitro Diagnostics Instruments Market Competitive Landscape
30.2. In-Vitro Diagnostics Instruments Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Diagnostics Instruments Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Hologic Inc.
31.3. Qiagen N.V.
31.4. Bio-Rad Laboratories Inc.
31.5. Agilent Technologies
31.6. Becton Dickinson and Company (BD)
31.7. Sysmex Corporation
31.8. Laboratory Corporation of America Holdings (LabCorp)
31.9. Guardant Health Inc.
31.10. Quest Diagnostics Inc.
31.11. Exact Sciences Corporation
31.12. Myriad Genetics Inc.
31.13. Natera Inc.
31.14. NeoGenomics Laboratories Inc.
31.15. NanoString Technologies Inc.

32. Global In-Vitro Diagnostics Instruments Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Diagnostics Instruments Market

34. Recent Developments In The In-Vitro Diagnostics Instruments Market

35. In-Vitro Diagnostics Instruments Market High Potential Countries, Segments and Strategies

35.1 In-Vitro Diagnostics Instruments Market In 2029 - Countries Offering Most New Opportunities
35.2 In-Vitro Diagnostics Instruments Market In 2029 - Segments Offering Most New Opportunities
35.3 In-Vitro Diagnostics Instruments Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer